DAVO 2 during exercise is a complex metric that incorporates into its calculation skeletal muscle blood flow and DmO 2 across the skeletal muscle capillary membrane.
HIGHLIGHTS
DAVO 2 during exercise is a complex metric that incorporates into its calculation skeletal muscle blood flow and DmO 2 across the skeletal muscle capillary membrane.
Although DAVO 2 was reduced in patients with HFpEF during both systemic and local (forearm) exercise, there was no difference in forearm DmO 2 among subjects with HFpEF, those with hypertension, and healthy control subjects; therefore, abnormalities in forearm DmO 2 cannot explain the reduced forearm DAVO 2 seen in subjects with HFpEF.
Local forearm exercise performance predicted about one-third of the variability in systemic aerobic capacity, demonstrating that peripheral factors are important in determining whole-body exercise tolerance.
Degree of adiposity strongly correlated with DAVO 2 during both local and whole-body exercise, suggesting that adipose tissue may play an active role in limiting exercise capacity in subjects with HFpEF.
SUMMARY
The aim of this study was to determine the arteriovenous oxygen content difference (DAVO 2 ) in adult subjects with and without heart failure with preserved ejection fraction (HFpEF) during systemic and forearm exercise.
Subjects with HFpEF had reduced DAVO 2 . Forearm diffusional conductance for oxygen, a lumped conductance parameter that incorporates all impediments to the movement of oxygen from red blood cells in skeletal muscle capillaries into the mitochondria within myocytes, was estimated. Forearm diffusional conductance for oxygen was not different among adults with HFpEF, those with hypertension, and healthy control subjects; therefore, diffusional conductance cannot explain the reduced forearm DAVO 2 . Instead, adiposity was strongly associated with DAVO 2 , suggesting an active role for adipose tissue in reducing exercise capacity in patients A n increasing number of patients have heart failure with preserved ejection fraction (HFpEF) (1), leading to hospitalizations and decreased quality of life (2) . The heterogeneity of the condition, in addition to its incompletely understood pathophysiologic mechanisms, has led to a dearth of effective therapeutic options for these patients (3) . In addition to myocardial abnormalities (4) , increasing evidence suggests that abnormalities outside the heart exist, giving rise to the possibility of "peripheral" contributors to exercise intolerance in patients with HFpEF. Several studies have focused on the arteriovenous oxygen content difference (DAVO 2 ), noting its reduction at peak exercise in subjects with HFpEF (5-7) and suggesting that this reflects impairments within the skeletal muscle itself.
However, DAVO 2 is a complex metric, as the movement of oxygen out of skeletal muscle capillaries and into mitochondria is governed both by its delivery to the skeletal muscle capillary network ("convec- has received advisory board honoraria from Actelion Pharmaceuticals (modest) and United Therapeutics (modest). Dr. Margulies is supported by NIH grants U10-HL110338, R01HL121510, and R01HL133080; and receives research funding from Sanofi (significant), Merck (significant), and GlaxoSmithKline (significant). Dr. Kelly is supported by NIH grants R01 DK045416, R01 HL058493, and R01 HL128349; and has received advisory board honoraria from Pfizer (significant) and Amgen (modest). Dr. Poole is supported by NIH grant HL-2-108328. Dr. Wagner is serving as an expert witness in a legal case of scientific misconduct. Dr. Chirinos is supported by NIH grants R01-HL 121510-01A1, R61-HL-146390, R01-AG058969, 1R01-HL104106, P01-HL094307, R03-HL146874-01, and R56-HL136730. Gregory Lewis, MD, served as guest editor for this paper. mitochondria ("diffusive transport") (8) . Because slower blood flow through the capillary can lead to greater oxygen extraction because of longer capillary transit time, DAVO 2 is not dependent solely on skeletal muscle properties (7) . In contrast, skeletal muscle diffusional conductance for oxygen (DmO 2 ) is a lumped parameter that summarizes all impediments to the transfer of oxygen from red blood cells into mitochondria, accounting for differences in blood flow. Thus, DmO 2 is a purer reflection of skeletal muscle properties than DAVO 2 , incorporating features such as capillarity, fiber size, and fiber composition into its determination. An assessment of DmO 2 is essential to help resolve the mechanistic basis for the deficits in DAVO 2 seen in patients with HFpEF.
We determined forearm DmO 2 in adults with HFpEF and control subjects using an exercise paradigm that engages the small muscle mass of the forearm and therefore is not constrained by limitations in cardiac output (CO) (9) . We hypothesized that subjects with HFpEF would exhibit lower DmO 2 , explaining their DAVO 2 abnormalities. Contrary to our hypothesis, we did not find reductions in forearm DmO 2 in subjects with HFpEF. Instead, we found the degree of adiposity to be a key correlate of DAVO 2 , supporting a deleterious role of body fat per se in patients with HFpEF and suggesting a novel mechanistic link between obesity and the limitations in aerobic capacity in patients with HFpEF.
METHODS
PARTICIPANTS. This was a cross-sectional analysis of subjects with HFpEF, patients with hypertension without heart failure symptoms, and healthy control subjects. Inclusion criteria for subjects with HFpEF included symptomatic heart failure (New York Heart Association functional class II or III) in the context of a preserved ejection fraction ($50%) and stable medical management for at least 1 month. Subjects were required to have evidence of elevated filling pressure, which included at least 1 of the following: 1) prior admission for heart failure requiring intravenous diuretic agents; 2) history of elevated invasively determined filling pressures (pulmonary capillary wedge pressure >15 mm Hg or left ventricular enddiastolic pressure >16 mm Hg); 3) mitral E/septal e 0 ratio >15; or 4) mitral E/e 0 ratio >8 in addition to 1 of 
bone mineral content], total mass, and percentage fat) and limb-specific composition data were obtained. A forward integration is performed during which the changes in oxygen and carbon dioxide content are simultaneously calculated along each step of the capillary. Skeletal muscle diffusional conductance for oxygen (DmO 2 ) is iteratively varied until the end-capillary contents match the measured venous blood gas contents for oxygen and carbon dioxide. pCO 2 ¼ partial pressure of carbon dioxide; pO 2 ¼ partial pressure of oxygen.
flow, or forearm VO 2 at maximal exertion; therefore, results from the 2 transients at each FIO 2 were averaged together to minimize variation.
A resting arterial blood gas sample was obtained once at each FIO 2 . Given the minimal demand of forearm exercise on whole-body exercise capacity, the arterial content was assumed to be constant throughout each forearm exercise transient (17).
Venous blood sampling from a deep vein has previously been shown to reflect forearm muscle metabolic activity during handgrip exercise, as evidenced by a commensurate rise in VO 2 with exercise (17-19).
Arterial and venous oxygen contents were determined as:
(mm Hg). Forearm VO 2 was determined as DAVO 2 multiplied by brachial artery blood flow.
In brief, a numeric integration procedure was performed such that, starting with arterial oxygen and carbon dioxide contents, the contents of both gases in capillary blood are incrementally changed as oxygen and carbon dioxide are exchanged across the capillary membrane in small time steps. For any given blood flow, the rate of movement across the membrane is governed by the diffusional conductance for the specific gas, where the diffusional conductance for carbon dioxide is assumed to be 20 times DmO 2 . The procedure is repeated iteratively, using different estimates for DmO 2 , until the calculated oxygen and carbon dioxide contents at the end of the skeletal muscle capillary match the directly measured venous blood gas contents ( Figure 1 ) (see the Supplemental Appendix for additional details on methodology) (9, 20, 21 In these models, estimated marginal means of brachial flow indexed to forearm lean muscle were computed to adjust for differences in muscle mass.
Analogous models were also created using systemic parameters to assess the change in systemic DAVO 2 as a function of the change in estimated marginal means of CO, indexed to total leg lean mass. We analyzed the relationships between body composition and local and systemic DAVO 2 using ordinary least squares 
basis of midrange mitral E/septal e 0 ratios of >8 and elevated NT-proBNP, and 3 were enrolled on the basis of midrange E/e 0 ratios and chronic loop diuretic agent use.
Demographic and medical history data are presented in Table 1 . Subjects with HFpEF were older, were more obese, and had typical comorbidities consistent with the disease, such as hypertension (100%), diabetes (55%), hyperlipidemia (90%), and obstructive sleep apnea (60%). Subjects with HFpEF exhibited higher NT-proBNP and lower hemoglobin concentrations. The tricuspid regurgitant jet velocity was higher in subjects with HFpEF, alongside an increased mitral E/septal e 0 ratio. On DEXA, subjects with HFpEF had marked increases in total body and forearm fat ( Table 1) .
CYCLE ERGOMETRIC EXERCISE DATA. Cycle ergometric exercise data are presented in Systemic DAVO 2 , calculated as the ratio of VO 2 to CO according to the Fick principle, was significantly lower at peak exercise in patients with HFpEF. Similarly, the oxygen pulse, which is derived from directly measured variables (oxygen pulse ¼ VO 2 /heart rate), was also reduced in patients with HFpEF ( Zamani et al. 
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<0.001
Values are median (interquartile range) or mean AE SD. RA and 100% represent overall group summary statistics for the transients at the given inspired oxygen concentrations. *HFpEF versus healthy, adjusted p < 0.05. †HFpEF versus HTN, adjusted p < 0.05. ‡The decrease in lactate at peak effort with oxygen, compared with RA, was significantly greater in healthy individuals than subjects with HFpEF.
DmO2 ¼ skeletal muscle diffusional conductance for oxygen; MVC ¼ maximal voluntary contraction force; PO2 ¼ partial pressure of oxygen; other abbreviations as in Tables 1 and 2 . A similar analysis was performed comparing systemic DAVO 2 to estimated CO, indexed to leg lean mass, during cycle ergometry. Because few subjects with HFpEF were able to complete the fourth stage of exercise, analyses were restricted to the first 3 stages of exercise to ensure representation of subjects with HFpEF at each time point. In these analyses, subjects with HFpEF tended to have lower DAVO 2 for any given estimated indexed CO (Supplemental Figure 2) (p ¼ 0.081).
MODELS PREDICTING DAVO 2 . Univariate predictors of the regional and systemic DAVO 2 are presented in Table 4 . Multivariate linear models were created to determine the independent correlates of the forearm arteriovenous oxygen content relationship for all subjects ( Table 4) . For any given DmO 2 and brachial blood flow, forearm tissue composition was a significant predictor of DAVO 2 , with an increase in forearm fat correlating with a reduced DAVO 2 .
Similar models were then created for systemic DAVO 2 , in which local determinants were substituted for their systemic counterparts (i.e., CO was substituted for brachial flow, and whole-body fat was substituted for forearm fat). In these models, body composition significantly predicted systemic DAVO 2 , with a negative correlation seen for body fat mass, while lean mass was positively correlated with systemic DAVO 2 .
RELATIONSHIP BETWEEN FOREARM VO 2 AND CYCLE ERGOMETRY VO 2 . Despite no difference in peak forearm VO 2 among groups, forearm VO 2 was moderately correlated with cycle ergometric peak VO 2 (r ¼ 0.53; p < 0.0001). Using linear regression, peak forearm VO 2 predicted 36% of the variability in cycle ergometric peak VO 2 ( Figure 3A ) (standardized
We then explored differences in this relationship among groups. Formal interaction testing revealed no differences in the slope of the relationship between The relationship between arteriovenous oxygen content difference (DAVO 2 ) and estimated brachial flow, indexed to forearm lean mass, during forearm exercise. Data are displayed as marginal means with 95% confidence intervals. HFpEF ¼ heart failure with preserved ejection fraction; HTN ¼ hypertension.
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forearm and cycle VO 2 ; however, there were differences in the main effects (i.e., group). For any given forearm VO 2 , the predicted cycle ergometric VO 2 was lower in subjects with HFpEF compared with healthy controls, with subjects with hypertension being roughly in the middle of the other groups ( Figure 3B) . longer red blood cell capillary transit times, and vice versa (7, 24) . Consistent with this notion, we found an inverse relationship between blood flow and DAVO 2 during both small-and large-muscle exercise, highlighting the complexity in assessing DAVO 2 in isolation and demonstrating that the Fick determinants of VO 2 (DAVO 2 and flow) are not independent (7,24).
In contrast, DmO 2 across the skeletal muscle capillary membrane is expressed per unit of time (milliliters of oxygen per minute per millimeter of mercury) and therefore is independent of differences in capillary transit time (9) . Recently, an elegant modeling study raised the possibility for reduced DmO 2 in subjects with HFpEF (7). That study focused on estimations of DmO 2 based on pulmonary artery blood gas samples obtained during cycle exercise.
Although intriguing, large-muscle exercise, such as cycle ergometry, might be influenced by central (i.e., cardiac) limitations, reaching a "ceiling" on skeletal muscle oxygen supply (9) . Moreover, as the investigators noted, the degree to which mixed venous blood in the pulmonary artery reflects the blood draining from the skeletal muscle may be variable between patients with HFpEF and control subjects, in part because of the abnormalities in systemic blood flow distribution and the vasodilatory reserve in patients with HFpEF (25) . In contrast, in the present investigation, we estimated DmO 2 during forearm exercise, a small-muscle modality that is not dependent upon peak CO, and we used local deep venous blood sampling, leading to measurements that focus exclusively on the factors driving local skeletal muscle oxygen utilization in the forearm. In our measurements, we did not find a reduction in such that more total oxygen can be extracted for any
given DmO 2 or increase forearm DmO 2 and allow greater fractional extraction (or ideally both; see the following discussion) need to be undertaken to improve DAVO 2 in patients with HFpEF (27) .
Interestingly, we found that body composition, particularly the degree of adiposity, was correlated with DAVO 2 , with increasing fat associated with reduced DAVO 2 . Three possible explanations exist for this finding. First, the adipose tissue within and around the myocytes could "steal" blood away from the exercising skeletal muscle (28, 29) . As the fat is less metabolically active, especially during exercise, the adipocytes would extract less oxygen than exercising muscle for any given flow, leading to a greater venous oxygen content in the draining vein. Second, the adipose tissue may have an impact on skeletal muscle metabolism and the mitochondria (29) .
Obesity is associated with impairments in skeletal muscle fuel utilization (30-32), mitochondrial content (33, 34) , and an increase in inflammation and reactive oxygen species (3, 35, 36) , which can also decrease mitochondrial function. The lower slope of the relationship between the change in forearm DAVO 2 as a function of indexed brachial flow in subjects with
HFpEF suggests abnormalities in oxygen utilization at the skeletal muscle (37, 38) . Third, obesity, as a source of chronic inflammation, may be an important contributor to the anemia commonly seen in HFpEF (39, 40) , leading to a lower arterial content, which may influence DAVO 2 . Although erythropoiesisstimulating agents increase hemoglobin concentration in patients with HFpEF, their use did not improve submaximal exercise capacity, as measured using the 6-min walk test (41), though changes in peak VO 2 were not assessed.
Perhaps the links between adiposity, mitochondrial function, and aerobic capacity in patients with Zamani et al.
HFpEF explain recent findings in clinical trials that: 1) We did not measure central filling pressures in our studies, and it is possible that although the CO-to-VO 2 relationship was preserved in patients with HFpEF It is tempting to speculate that simply a reduction in absolute muscle mass could explain many of our findings. However, we found no difference in the absolute amount of lean mass across groups (data not shown) on DEXA (29, 38) , and the differences in whole-body exercise persisted, even when indexing systemic VO 2 to lean leg mass (38, 42) . Instead, the amount of fat mass, and the ratio of fat mass to total mass (which takes lean mass into account), were strikingly divergent among groups (29, 38, 42 
